Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
IsraelRecruitingPHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Von Hippel-Lindau Disease · Carcinoma, Renal Cell
Locations
- START San Antonio ( Site 0104), San Antonio, Texas, United States
- Sourasky Medical Center ( Site 1603), Tel Aviv, Israel
- Russian Scientific Center of Radiology and Surgical Technologies ( Site 2100), Saint Petersburg, Sankt-Peterburg, Russia
- Samsung Medical Center ( Site 2902), Gangnam, Seoul, South Korea
- Severance Hospital, Yonsei University Health System ( Site 2901), Seodaemun-gu, Seoul, South Korea
- Taipei Veterans General Hospital ( Site 2800), Taipei, Taiwan
- ME І.І. Mechnykov Dnipro Regional Clinical Hospital ( Site 2601), Dnipropetrovsk, Dnipropetrovsk Oblast, Ukraine
- CNCE Precarpathian Clinical Oncologic Center ( Site 2600), Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine